Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 16th November 2016
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Product recall after flea products mislabelled
product recall
(Caption here)

Dog treatment containing permethrin labelled as a cat product

A dog flea treatment containing permethrin, which is often fatal to cats, has been accidentally labelled as a cat product.

Information supplied by the Veterinary Medicines Directorate (VMD):

Product defect recall alert for Armitage Pet Care Flea and Tick Drops for Dogs and Armitage Flea Drops for Cats & Kittens manufactured by Bio-Tech Solutions Ltd.

We wish to make wholesalers, veterinary surgeons, retailers and pet owners aware that the VMD has been notified that Bio-Tech Solutions Ltd has issued a recall of:

  • Armitage Pet Care Flea and Tick Drops for Dogs 702 mg spot-on solution (Vm 20205/4003)
  • Armitage Flea Drops for Cats and Kittens


An unknown quantity of the Armitage Pet Care Flea and Tick Drops for Dogs containing permethrin has been distributed in packaging labelled Armitage Flea Drops for Cats and Kittens.

Exposure to even small quantities of concentrated permethrin can cause severe and fatal poisoning in cats.

If you have one of the products, do not use it on your cat.

Return the product to the place of purchase or contact the company:
John Tharratt, Bio-Tech solutions Tel 08704 450154 or email JTharratt@btsl.uk.com.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.